Free Trial
NASDAQ:DFNS

Nukkleus Q1 2024 Earnings Report

Nukkleus logo
$0.44 -0.02 (-3.70%)
As of 05/15/2026 04:00 PM Eastern

Nukkleus EPS Results

Actual EPS
-$0.88
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Nukkleus Revenue Results

Actual Revenue
$0.18 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Nukkleus Announcement Details

Quarter
Q1 2024
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Nukkleus Earnings Headlines

Nukkleus (NASDAQ:DFNS) Shares Down 9% - Here's Why
The gold strategy that works whether prices rise or fall
Former $900 million hedge fund manager Larry Benedict has developed a strategy he calls Gold Skimming - a way to target cash payouts from gold markets without buying a single ounce, mining stock, or ETF. With a reported 73% win rate across 19 trades and potential payouts of $2,975, $3,781, and $6,786 in a single day, Benedict has put together a free step-by-step walkthrough showing how it works whether gold climbs or pulls back.tc pixel
T3 Defense Faces New Legal Dispute Over Success Fee
See More Nukkleus Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nukkleus? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nukkleus and other key companies, straight to your email.

About Nukkleus

Nukkleus (NASDAQ:DFNS), a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions. Nukkleus Inc. was founded in 2013 and is headquartered in Jersey City, New Jersey.

View Nukkleus Profile